Imipramine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 9 USDMF, 1 EU WC, 1 NDC API, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 16 FDA Orange Book, 4 Europe, 3 Australia, 2 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 8 DKSH, 2 Gangwal Healthcare, 4 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Keval Exports, 3 Lonza Capsugel, 5 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 10 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 12 Disintegrants & Superdisintegrants, 8 Empty Capsules, 8 Coating Systems & Additives, 8 Thickeners and Stabilizers, 6 Direct Compression, 6 Taste Masking, 5 Granulation, 4 Co-Processed Excipients, 3 Chewable & Orodispersible Aids, 3 Coloring Agents, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 Controlled & Modified Release, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 Others

3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 17090 / DOSAGE - CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
IMIPRAMINE PAMOATE(UNII: MC34P30298) (IMIPRAMINE - UNII:OGG85SX4E4)	IMIPRAMINE	75mg \| 100mg \| 125mg \| 150mg

Inactive Ingredients

Ingredient Name	Mallinckrodt, Inc.
D&C RED NO. 28(767IP0Y5NH)
D&C YELLOW NO. 10(35SW5USQ3G)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C YELLOW NO. 6(H77VEI93A8)
GELATIN(2G86QN327L)
MAGNESIUM STEARATE(70097M6I30)
METHYLPARABEN(A2I8C7HI9T)
PROPYLPARABEN(Z8IX2SC1OH)
STARCH, CORN(O8232NY3SJ)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Setid 75c986bd E51f 4f8c 9590 0df4718d0b9e Applno 17090 Form Capsule Oral Dosage Eq 125mg Hydrochloride - Drug Product Composition: Imipramine

Imipramine

Imipramine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

9 USDMF

1 EU WC

1 NDC API

3 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers

16 FDA Orange Book

4 Europe

3 Australia

2 South Africa

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

8 DKSH

2 Gangwal Healthcare

4 ACG Worldwide

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 DFE Pharma

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Keval Exports

3 Lonza Capsugel

5 Microlex e.U

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

10 Roquette

1 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Silverline Chemicals

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

15 Lubricants & Glidants

12 Disintegrants & Superdisintegrants

8 Empty Capsules

8 Coating Systems & Additives

8 Thickeners and Stabilizers

6 Direct Compression

6 Taste Masking

5 Granulation

4 Co-Processed Excipients

3 Chewable & Orodispersible Aids

3 Coloring Agents

3 Emulsifying Agents

3 Film Formers & Plasticizers

2 Controlled & Modified Release

1 Surfactant & Foaming Agents

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons